Cheng Miao, Qin Zongyi, Hu Shuo, Dong Shu, Ren Zichu, Yu Houyong
State Key Laboratory for Modification of Chemical Fibers and Polymer Materials and College of Material Science and Engineering, Donghua University, No. 2999 North Renmin Road, Songjiang, Shanghai 201620, China.
The Key Laboratory of Advanced Textile Materials and Manufacturing Technology of Ministry of Education, College of Materials and Textile, Zhejiang Sci-Tech University, Hangzhou 310018, China.
ACS Biomater Sci Eng. 2017 Aug 14;3(8):1666-1676. doi: 10.1021/acsbiomaterials.7b00169. Epub 2017 Jun 6.
Electrospun nanofibrous membranes of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) seems not to be ideal for biomedical applications because of their hydrophobicity, and high crystallinity, as well as weak mechanical properties. It is found that hydrophilic drug such as tetracycline hydrochloride (TH) generally is located on the hydrophobic surface of electrospun PHBV nanofibrous membranes, leading to fast drug release. Therefore, we used cellulose nanocrystals (CNCs) as rigid organic nanofillers for PHBV nanofibrous membranes to enhance their mechanical, thermal, and hydrophilic properties. The influences of the CNC contents on microstructures and properties of composite nanofibrous membranes were studied. It is found that at 6 wt % CNC content, the increase of tensile strength by 125%, Young's modulus by 110%, and maximum decomposition temperature () by 24.3 °C could be achieved, which could be contributed to strong hydrogen bonding between PHBV and CNCs. Moreover, with the introducing of the hydrophilic CNCs, the hydrophilicity of composite nanofibrous membranes was improved gradually. More importantly, good cytocompatibility, high drug loading and long-term sustained release property of composite nanofibrous membranes could be achieved. The maximum drug loading and drug loading efficiency were 25 and 98.8%, respectively, and more than 86% drug content was delivered within 540 h for the nanofibrous composite membranes with 6 wt % CNC content.
聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(PHBV)的静电纺纳米纤维膜由于其疏水性、高结晶度以及较弱的机械性能,似乎并不适合生物医学应用。研究发现,亲水性药物如盐酸四环素(TH)通常位于静电纺PHBV纳米纤维膜的疏水表面,导致药物快速释放。因此,我们使用纤维素纳米晶体(CNCs)作为PHBV纳米纤维膜的刚性有机纳米填料,以增强其机械、热和亲水性能。研究了CNC含量对复合纳米纤维膜微观结构和性能的影响。结果发现,当CNC含量为6 wt%时,拉伸强度可提高125%,杨氏模量可提高110%,最大分解温度可提高24.3℃,这可能归因于PHBV与CNCs之间强大的氢键作用。此外,随着亲水性CNCs的引入,复合纳米纤维膜的亲水性逐渐提高。更重要的是,复合纳米纤维膜可实现良好的细胞相容性、高载药量和长期缓释性能。对于CNC含量为6 wt%的纳米纤维复合膜,最大载药量和载药效率分别为25%和98.8%,且在540小时内超过86%的药物含量被释放。